Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 302,376 | 240,571 | 214,780 | 299,722 | 299,527 |
| Cost of Goods | 38,629 | 31,259 | 34,383 | 31,027 | 30,893 |
| Gross Profit | 263,747 | 209,312 | 180,397 | 268,695 | 268,634 |
| Operating Expenses | 195,705 | 197,017 | 188,385 | 184,119 | 175,574 |
| Operating Income | 68,671 | 12,554 | -7,605 | 84,603 | 93,953 |
| Interest Expense | 45 | 47 | 87 | 29 | 35 |
| Other Income | 5,628 | 5,346 | 1,884 | 3,208 | 2,629 |
| Pre-tax Income | 74,254 | 17,853 | -5,808 | 87,782 | 96,547 |
| Income Tax | -24,104 | -9,001 | -9,067 | 22,432 | 149,705 |
| Net Income Continuous | 98,358 | 26,854 | 3,259 | 65,350 | -53,158 |
| Minority Interests | 139 | 138 | 143 | 134 | 144 |
| Net Income | $98,219 | $26,716 | $3,116 | $65,216 | $-53,302 |
| EPS Basic Total Ops | 0.96 | 0.26 | 0.03 | 0.63 | -0.52 |
| EPS Basic Continuous Ops | 0.96 | 0.27 | 0.03 | 0.63 | -0.52 |
| EPS Diluted Total Ops | 0.93 | 0.27 | 0.03 | 0.61 | -0.52 |
| EPS Diluted Continuous Ops | 0.93 | 0.27 | 0.03 | 0.61 | -0.52 |
| EBITDA(a) | $89,009 | $32,866 | $13,683 | $106,135 | $114,577 |